Development of inhibitors in hemophilia A: An illustrated review

Research and Practice in Thrombosis and Haemostasis
Letícia Lemos JardimSuely Meireles Rezende

Abstract

This illustrated review focuses on the development of inhibitors in patients with congenital hemophilia, which is the most serious treatment-related complication in these patients. Hemophilia A (HA) is an inherited X-linked bleeding disorder affecting 1:5000-10 000 newborn males worldwide. It results from the deficiency of coagulation factor VIII (FVIII), due to mutation(s) in its coding gene (F8). Treatment requires administration of FVIII-containing products either on demand or as prophylaxis, which can induce inhibitor development in 20%-35% of patients. Inhibitors are alloantibodies that neutralize the procoagulant activity of exogenous FVIII. During the initial administration of FVIII-containing products, patients with HA can develop a proinflammatory immune response with synthesis of anti-FVIII IgG1, which has no FVIII inhibitory activity. However, in patients with inhibitors, immune response shifts toward an anti-inflammatory/regulatory pattern favoring the synthesis of anti- FVIII IgG4 antibodies. Patients with inhibitors present with bleeding episodes that are difficult to control, and they have reduced response to FVIII replacement. Currently, immune tolerance induction is the available treatment for eradication of pe...Continue Reading

References

Nov 22, 1984·Nature·J GitschierR M Lawn
Feb 21, 2006·Thrombosis Research·Hong FangHongbao Wang
Nov 6, 2008·Journal of Thrombosis and Haemostasis : JTH·P C ter AvestUNKNOWN CANAL Study Group
Feb 25, 2015·Haemophilia : the Official Journal of the World Federation of Hemophilia·S A L MontalvãoM C Ozelo
May 26, 2016·The New England Journal of Medicine·Flora PeyvandiFrits R Rosendaal
Dec 13, 2017·Seminars in Thrombosis and Hemostasis·Assaf Arie BargGili Kenet
Jun 5, 2018·Seminars in Thrombosis and Hemostasis·Sandrine DelignatUNKNOWN ABIRISK consortium

❮ Previous
Next ❯

Citations

Jun 16, 2021·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Letícia L JardimSuely M Rezende
Nov 17, 2021·Expert Opinion on Biological Therapy·Steven W PipeOscar G Segurado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology
Akira Ishiguro
Haemophilia : the Official Journal of the World Federation of Hemophilia
C A OliveiraD G Chaves
© 2021 Meta ULC. All rights reserved